Analyst Price Target is $131.22
▲ +∞ Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Revvity in the last 3 months. The average price target is $131.22, with a high forecast of $165.00 and a low forecast of $54.00. The average price target represents a ∞ upside from the last price of $0.00.
Current Consensus is
The current consensus among 8 investment analysts is to moderate buy stock in Revvity. This Moderate Buy consensus rating has held steady for over two years.
Revvity, Inc provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics.? The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937, and is headquartered in Waltham, MA.